93 related articles for article (PubMed ID: 11874945)
1. The Gly972Arg polymorphism in insulin receptor substrate-1 is associated with decreased birth weight in a population-based sample of Brazilian newborns.
Bezerra RM; de Castro V; Sales T; Passini R; Marba ST; Saad ST; Saad MJ
Diabetes Care; 2002 Mar; 25(3):550-3. PubMed ID: 11874945
[TBL] [Abstract][Full Text] [Related]
2. The polymorphism in insulin receptor substrate-1 gene and birth weight in neonates at term.
Simońska-Cichocka E; Gumprecht J; Zychma M; Witkowska A; Misiołek H; Slawska H; Oslislo A; Grzeszczak W
Endokrynol Pol; 2008; 59(3):212-6. PubMed ID: 18615395
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin receptor substrate 1 gene polymorphism Gly972Arg as a risk factor for ischemic stroke among Indonesian subjects.
Syahrul ; Wibowo S; Haryana SM; Astuti I; Nurwidya F
BMC Res Notes; 2018 Oct; 11(1):718. PubMed ID: 30305144
[TBL] [Abstract][Full Text] [Related]
4. The Gly972Arg variant in insulin receptor substrate-1 is not associated with birth weight in contemporary English children. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
Mason S; Ong KK; Pembrey ME; Woods KA; Dunger DB
Diabetologia; 2000 Sep; 43(9):1201-2. PubMed ID: 11043868
[No Abstract] [Full Text] [Related]
5. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
[TBL] [Abstract][Full Text] [Related]
6. The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans.
Stumvoll M; Fritsche A; Volk A; Stefan N; Madaus A; Maerker E; Teigeler A; Koch M; Machicao F; Häring H
Diabetes; 2001 Apr; 50(4):882-5. PubMed ID: 11289056
[TBL] [Abstract][Full Text] [Related]
7. [The influence of polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-alpha gene on obesity and insulin resistance in children with obesity].
Pyrzak B; Wiśniewska A; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):175-8. PubMed ID: 17020651
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism analysis of the Gly972Arg IRS-1 and Gly1057Asp IRS-2 genes in obese pregnant women.
Górska A; Wolek M; Czerny B; Uzar I; Seremak-Mrozikiewicz A; Olbromski P; Baraniak J; Kania-Dobrowolska M; Sienko M; Bogacz A
Reprod Biol; 2020 Sep; 20(3):365-370. PubMed ID: 32540195
[TBL] [Abstract][Full Text] [Related]
9. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
[TBL] [Abstract][Full Text] [Related]
10. Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load.
Sir-Petermann T; Angel B; Maliqueo M; Santos JL; Riesco MV; Toloza H; Pérez-Bravo F
Nutrition; 2004 Oct; 20(10):905-10. PubMed ID: 15474880
[TBL] [Abstract][Full Text] [Related]
11. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies.
van Dam RM; Hoebee B; Seidell JC; Schaap MM; Blaak EE; Feskens EJ
Diabet Med; 2004 Jul; 21(7):752-8. PubMed ID: 15209769
[TBL] [Abstract][Full Text] [Related]
12. Association of ADIPOQ, LEP, and FTO gene polymorphisms with large for gestational age infants.
Kroll C; Mastroeni SS; Veugelers PJ; Mastroeni MF
Am J Hum Biol; 2017 Jan; 29(1):. PubMed ID: 27392994
[TBL] [Abstract][Full Text] [Related]
13. The study on the relationship between IRS-1 Gly972Arg and IRS-2 Gly1057Asp polymorphisms and type 2 diabetes in the Kurdish ethnic group in West Iran.
Haghani K; Bakhtiyari S
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1270-6. PubMed ID: 22994406
[TBL] [Abstract][Full Text] [Related]
14. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.
Yamada K; Yuan X; Ishiyama S; Shoji S; Kohno S; Koyama K; Koyanagi A; Koyama W; Nonaka K
Diabetes Care; 1998 May; 21(5):753-6. PubMed ID: 9589236
[TBL] [Abstract][Full Text] [Related]
15. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.
El Mkadem SA; Lautier C; Macari F; Molinari N; Lefèbvre P; Renard E; Gris JC; Cros G; Daurès JP; Bringer J; White MF; Grigorescu F
Diabetes; 2001 Sep; 50(9):2164-8. PubMed ID: 11522686
[TBL] [Abstract][Full Text] [Related]
16. Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis.
Shi X; Xie X; Jia Y; Li S
J Obstet Gynaecol Res; 2016 Jul; 42(7):844-54. PubMed ID: 27098445
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity is not affected by mutation of codon 972 of the human IRS-1 gene.
Ito K; Katsuki A; Furuta M; Fujii M; Tsuchihashi K; Hori Y; Yano Y; Sumida Y; Adachi Y
Horm Res; 1999; 52(5):230-4. PubMed ID: 10844412
[TBL] [Abstract][Full Text] [Related]
18. [Influence of angiotensin converting enzyme gene insertion/deletion polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on fetal growth and neonatal insulin sensitivity].
Cui YP; Han TY; Wang XL; Ye HM
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):421-7. PubMed ID: 19099777
[TBL] [Abstract][Full Text] [Related]
19. Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese noninsulin-dependent diabetes mellitus.
Mori H; Hashiramoto M; Kishimoto M; Kasuga M
J Clin Endocrinol Metab; 1995 Sep; 80(9):2822-6. PubMed ID: 7673430
[TBL] [Abstract][Full Text] [Related]
20. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Turkish with type 2 diabetes mellitus.
Orkunoglu Suer FE; Mergen H; Bolu E; Ozata M
Endocr J; 2005 Oct; 52(5):593-8. PubMed ID: 16284438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
